Skip to content

SenesTech

SenesTech is an agricultural biotechnology company that develops fertility-management products for controlling pest populations.

Last updated August 31, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

SenesTech, Inc. is an agricultural biotechnology and life-sciences company focused on fertility management as a method of pest control. Its principal commercial product, ContraPest, is intended to reduce the reproduction of brown and black rats by delivering reproductive-control compounds through an attractive liquid bait. Rather than killing rodents directly, the product is designed to reduce the number of future offspring produced by treated populations. The company originated from research into menopause and reproductive biology in rodents. Dr. Loretta Mayer and colleagues recognized that their findings could have applications beyond laboratory research, particularly in managing pest populations through reproductive suppression. SenesTech was incorporated in 2004 to develop those applications commercially. The company’s approach differs from conventional rodent-control methods that rely primarily on trapping, poisoning, or other lethal interventions. ContraPest is intended to be consumed by rats and to affect reproductive capacity in both males and females. Its active ingredients include 4-vinylcyclohexene diepoxide, commonly abbreviated VCD, and triptolide. VCD reduces oocytes in immature ovarian follicles, while triptolide contributes reproductive effects across both sexes. The product does not permanently sterilize treated animals, meaning that ongoing availability is required to maintain population-suppression effects. ContraPest received approval from the United States Environmental Protection Agency for commercial use in August 2016. In October 2018, the EPA permitted removal of the product’s “Restricted Use Only” label, broadening the circumstances in which it could be used. SenesTech began selling directly to the public in 2019, marking a shift from a primarily institutional or professional commercialization model toward access for a wider customer base. SenesTech’s positioning centers on non-lethal or fertility-based population management. The company presents reproductive control as a way to address persistent rodent populations while reducing dependence on methods that kill individual animals without necessarily addressing population replacement. Its business scope remains concentrated around pest-control applications of reproductive biology, with ContraPest as the principal offering identified in the available reference material. The company is headquartered in Phoenix, Arizona.

History

SenesTech developed from research into reproductive aging and menopause in rodents. Dr. Loretta Mayer and several colleagues were studying rodent reproductive biology when they identified potential commercial applications for their findings. Instead of using the research only to understand reproductive decline, the group explored whether fertility-related mechanisms could be applied to pest management. This work led to the incorporation of SenesTech in 2004. The company’s central concept was fertility management as a form of population control. Conventional rodent-control programs often focus on removing or killing existing animals. SenesTech pursued a different approach: a product that rats would consume as bait and that would reduce their ability to generate future offspring. This strategy was intended to address population growth over time rather than only the immediate presence of individual rodents. The principal result of this development program was ContraPest, a sugary liquid formulation designed to attract brown and black rats. The formulation contains 4-vinylcyclohexene diepoxide, or VCD, and triptolide. VCD reduces oocytes in immature ovarian follicles, while triptolide produces reproductive effects in both male and female rats. ContraPest is not described as permanently sterilizing treated animals. Because its effects do not eliminate reproductive capacity forever, continued access to the product is necessary for ongoing population suppression. ContraPest reached an important regulatory milestone in August 2016, when the United States Environmental Protection Agency approved it for commercial use. A further regulatory change came in October 2018, when the EPA permitted removal of the product’s “Restricted Use Only” label. This adjustment allowed the product to be used under less restrictive conditions than before, subject to the applicable regulatory requirements. In 2019, SenesTech began selling directly to the public. Direct sales represented a commercial expansion beyond a model focused only on professional or institutional users and made the product available to a broader customer base. The company remained headquartered in Phoenix, Arizona. SenesTech’s documented history is closely tied to the development and commercialization of ContraPest. The available reference material does not identify additional major product lines, acquisitions, corporate restructurings, financial results, or leadership changes. Its enduring strategic identity is the application of reproductive science to rodent population management, with fertility suppression positioned as an alternative or complement to more traditional pest-control techniques.

  • 2019

    Direct-to-public sales begin

    [1]

    SenesTech began selling ContraPest directly to the public.

  • 2018

    Restricted-use label removed

    [1]

    The EPA permitted removal of ContraPest’s “Restricted Use Only” label.

  • 2016

    ContraPest receives EPA commercial-use approval

    [1]

    The United States Environmental Protection Agency approved ContraPest for commercial use against brown and black rats.

  • 2004

    SenesTech is incorporated

    [1]

    Dr. Loretta Mayer and colleagues incorporated SenesTech after identifying commercial pest-control applications for their rodent reproductive-biology research.

Products and positioning

SenesTech positions itself at the intersection of agricultural biotechnology, reproductive biology, and pest management. Its differentiated proposition is to suppress rodent populations by reducing fertility rather than relying solely on lethal control.

  • Rodent fertility-control bait · 2016

    ContraPest

    ContraPest is a sugary liquid bait formulated to attract brown and black rats. It is designed to reduce future reproduction rather than directly sterilize or kill the animals. Its active ingredients are 4-vinylcyclohexene diepoxide, which reduces oocytes in immature ovarian follicles, and triptolide, which has reproductive effects in both male and female rats. Continued supply is required because the product does not permanently eliminate fertility. The EPA approved it for commercial use in 2016 and later allowed removal of its restricted-use labeling.

Brand decisions

  • 2019

    Direct-to-public distribution beginsStrategy

    Background

    SenesTech sought to expand access to its rodent fertility-control product beyond professional or institutional channels.

    Action taken

    The company began selling directly to the public.

    Aftermath

    ContraPest became available through a broader consumer-facing distribution model.

  • 2018

    Regulatory-use classification broadenedStrategy

    Background

    ContraPest had carried a “Restricted Use Only” label under its earlier regulatory classification.

    Action taken

    The EPA permitted removal of the restricted-use label.

    Aftermath

    The product could be used under less restrictive conditions, subject to applicable EPA requirements.

  • 2016

    Commercial launch of ContraPestProduct launch

    Background

    SenesTech developed a reproductive-control product intended to manage brown and black rat populations through fertility suppression.

    Action taken

    Following EPA approval, the company commercialized ContraPest for pest-control use.

    Aftermath

    ContraPest became SenesTech’s principal identified commercial product.

Recent events

  • 2019

    SenesTech begins direct-to-public sales[1]

    Product launch

    SenesTech began selling ContraPest directly to the public, expanding the product’s commercial distribution model.

  • 2018

    EPA permits removal of ContraPest restricted-use labeling[1]

    Regulation

    The EPA permitted the removal of the product’s “Restricted Use Only” label, changing its regulatory-use classification.

  • 2016

    EPA approves ContraPest for commercial use[1]

    Product launch · Regulation

    The United States Environmental Protection Agency approved ContraPest for commercial use as a reproductive-control product for brown and black rats.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/senestech · Editorial policy · How profiles are compiled